- BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
- BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
- BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
- BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
- BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
- BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
- BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
- BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
- BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE DECLARES DIVIDEND
More ▼
Key statistics
On Tuesday, Bio-Techne Corp (TECH:NSQ) closed at 63.69, 22.98% above the 52 week low of 51.79 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 64.00 |
---|---|
High | 64.59 |
Low | 63.56 |
Bid | 62.78 |
Offer | 63.86 |
Previous close | 62.80 |
Average volume | 1.00m |
---|---|
Shares outstanding | 157.19m |
Free float | 155.66m |
P/E (TTM) | 45.30 |
Market cap | 9.87bn USD |
EPS (TTM) | 1.39 USD |
Annual div (ADY) | 0.32 USD |
---|---|
Annual div yield (ADY) | 0.51% |
Div ex-date | Feb 09 2024 |
Div pay-date | Feb 26 2024 |
Data delayed at least 15 minutes, as of Apr 23 2024 21:00 BST.
More ▼